Literature DB >> 22369082

Suicide risk assessment in clinical practice: pragmatic guidelines for imperfect assessments.

James Christopher Fowler1.   

Abstract

This practice review focuses on the challenges of conducting sensitive and accurate assessments of the relative risk for suicide attempts and completed suicides. Suicide and suicide attempts are a frequently encountered clinical crisis, and the assessment, management, and treatment of suicidal patients is one of the most stressful tasks for clinicians. An array of risk factors, warning signs, and protective factors associated with suicide risk are reviewed; however, we are not yet in possession of evidence-based diagnostic tests that can accurately predict suicide risk on an individual level without also creating an inordinate number of false-positive predictions. Given the current limitations of assessment strategies, clinicians are advised to keep in mind that patients contemplating suicide are under enormous psychological distress, requiring sensitive and thoughtful engagement during the assessment process. An overarching goal of these assessments should be conducted within the therapeutic frame, in which efforts are made to enhance the therapeutic alliance by negotiating a collaborative approach to assessing risk and understanding why thoughts of suicide are so compelling. Within this treatment heuristic, the Suicide Assessment Five-step Evaluation and Triage (SAFE-T) is recommended as a pragmatic multidimensional assessment protocol incorporating the best known risk and protective factors. PsycINFO Database Record (c) 2012 APA, all rights reserved

Entities:  

Mesh:

Year:  2012        PMID: 22369082     DOI: 10.1037/a0026148

Source DB:  PubMed          Journal:  Psychotherapy (Chic)        ISSN: 0033-3204


  31 in total

Review 1.  Addressing suicidality in primary care settings.

Authors:  J Michael Bostwick; Sandra Rackley
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

2.  Suicide risk and associated demographic and clinical correlates among primary care patients with recent drug use.

Authors:  Adam Carmel; Richard Ries; Imara I West; Kristin Bumgardner; Peter Roy-Byrne
Journal:  Am J Drug Alcohol Abuse       Date:  2016-02-24       Impact factor: 3.829

Review 3.  Suicide Risk Assessment and Prevention: Challenges and Opportunities.

Authors:  Eileen P Ryan; Maria A Oquendo
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

4.  Does the timing of suicide risk assessments influence ratings of risk severity?

Authors:  Carol Chu; Kimberly A Van Orden; Jessica D Ribeiro; Thomas E Joiner
Journal:  Prof Psychol Res Pr       Date:  2017-04

5.  Are the "Right" People Selected for First Disclosures About Suicidal Thoughts? Exploring What We Know About Advance Care Planning in the Context of Safety Planning.

Authors:  Anthony Fulginiti; Laura M Frey
Journal:  Community Ment Health J       Date:  2019-09-11

6.  "Zero Suicide" - A model for reducing suicide in United States behavioral healthcare.

Authors:  Christa D Labouliere; Prabu Vasan; Anni Kramer; Greg Brown; Kelly Green; Mahfuza Rahman; Jamie Kammer; Molly Finnerty; Barbara Stanley
Journal:  Suicidologi       Date:  2018

Review 7.  Psychiatric Emergencies: Assessing and Managing Suicidal Ideation.

Authors:  Andrea N Weber; Maria Michail; Alex Thompson; Jess G Fiedorowicz
Journal:  Med Clin North Am       Date:  2017-03-08       Impact factor: 5.456

8.  Prenatal genetic counselling for psychiatric disorders.

Authors:  Angela Inglis; Emily Morris; Jehannine Austin
Journal:  Prenat Diagn       Date:  2016-08-23       Impact factor: 3.050

9.  Evaluation of a Suicide Risk Assessment Tool in a Large Sample of Detained Youth.

Authors:  Hygiea Casiano; Shay-Lee Bolton; Laurence Y Katz; James M Bolton; Jitender Sareen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2019-11-01

10.  Zero suicide implementation-effectiveness trial study protocol in outpatient behavioral health using the A-I-M suicide prevention model.

Authors:  Barbara Stanley; Christa D Labouliere; Gregory K Brown; Kelly L Green; Hanga C Galfalvy; Molly T Finnerty; Prabu Vasan; Anni Kramer Cummings; Milton Wainberg; Jay W Carruthers; Lisa B Dixon
Journal:  Contemp Clin Trials       Date:  2020-11-18       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.